Press Release

Interventional Oncology Devices Market to Grow at 7.86% CAGR through 2029

Rise of personalized medicine and targeted therapies is poised to revolutionize the field of interventional oncology which is expected to drive the Global Interventional Oncology Devices Market growth in the forecast period, 2025-2029.

 

According to TechSci Research report, “Interventional Oncology Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Interventional Oncology Devices Market stood at USD 2.54 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 7.86% through 2029.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Interventional Oncology Devices Market

The Global Interventional Oncology Devices Market is experiencing substantial growth driven by various influential factors. As cancer remains a significant global health concern, there is an urgent demand for innovative treatment modalities to address its complexities effectively. Interventional oncology devices have emerged as indispensable tools in the diagnosis, treatment, and management of diverse cancer types. These devices empower healthcare professionals to conduct minimally invasive procedures that precisely target tumors while minimizing harm to surrounding healthy tissues. This approach offers notable advantages over conventional surgical interventions, including shorter recovery periods, reduced complication risks, and enhanced patient outcomes.

Technological advancements have been instrumental in reshaping the interventional oncology devices market landscape. Innovations in imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, have significantly improved tumor localization and treatment planning accuracy. Additionally, the development of novel catheter-based devices, advanced ablation techniques, and innovative embolization agents has broadened clinicians treatment options, thereby propelling market expansion.

The increasing adoption of image-guided therapies, such as radiofrequency ablation (RFA), microwave ablation (MWA), and transcatheter arterial chemoembolization (TACE), underscores the rising demand for interventional oncology devices. These therapies offer tailored treatment approaches customized to individual patient requirements, resulting in enhanced clinical outcomes and patient satisfaction.

The expansion of healthcare infrastructure, particularly in emerging markets, has facilitated greater accessibility to advanced medical technologies, including interventional oncology devices. Governments and healthcare organizations are making significant investments in developing healthcare facilities equipped with state-of-the-art diagnostic and treatment modalities to tackle the growing cancer burden. This expansion of healthcare infrastructure is driving the uptake of interventional oncology devices and fueling market growth.

Collaboration among industry players, healthcare institutions, and research organizations is a driving force behind the market's growth. Through collaborative efforts, stakeholders can leverage synergies and complementary strengths to accelerate innovation, conduct robust clinical trials, and formulate effective market access strategies. These collaborative endeavors play a pivotal role in advancing the field of interventional oncology and widening the availability of cutting-edge treatment options for cancer patients worldwide.

The Global Interventional Oncology Devices Market is poised for sustained growth driven by technological advancements, increasing adoption of image-guided therapies, expansion of healthcare infrastructure, and collaborative efforts among industry stakeholders. With cancer prevalence on the rise and the demand for minimally invasive treatment options escalating, the market is expected to witness continued expansion in the foreseeable future.

The Global Interventional Oncology Devices Market is segmented into product, procedure, cancer type, regional distribution, and company

Based on cancer type, the Liver cancer stands out as a dominant force in the Global Interventional Oncology Devices Market, driven by several factors. Liver cancer holds a prominent position among the most prevalent and fatal cancer types worldwide. This prevalence has spurred significant investments in research and development aimed at advancing treatment modalities, including interventional oncology devices.

Interventional oncology devices have demonstrated remarkable efficacy in the treatment of liver cancer, offering minimally invasive options for tumor ablation and targeted embolization. These devices, including ablation devices, embolization devices, and support devices, play a pivotal role in managing liver cancer by providing precise and effective treatment options. Moreover, the escalating incidence of hepatocellular carcinoma, the predominant form of liver cancer, further amplifies the demand for interventional oncology devices tailored to address liver tumors. These factors underscore the dominance of liver cancer in driving the growth of the Global Interventional Oncology Devices Market.

Based on region, North America's dominance in the global interventional oncology devices market. At the forefront is the region's formidable healthcare infrastructure, boasting state-of-the-art medical facilities and advanced diagnostic and therapeutic technologies. This robust infrastructure enables healthcare providers to deliver cutting-edge interventions and treatments with unparalleled precision and efficacy.

North America's unwavering commitment to research and development stands as a cornerstone of its leadership in the field of interventional oncology. Substantial investments in pioneering medical innovations and treatments underscore the region's dedication to advancing the boundaries of medical science. This relentless pursuit of innovation not only enhances patient care but also positions North America as a driving force in shaping the future of interventional oncology on a global scale.

Major companies operating in Global Interventional Oncology Devices Market are:

  • Medtronic PLC
  • Terumo Corporation
  • Boston Scientific Corporation
  • Merit Medical Systems, Inc.
  • HealthTronics, Inc.
  • Johnson & Johnson
  • Teleflex Inc.
  • Angiodynamics Inc.
  • MedWaves, Inc.
  • Becton, Dickinson, and Company

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The future of the Interventional Oncology Devices Market is poised for remarkable growth and transformation, driven by a convergence of technological advancements, evolving treatment paradigms, and shifting healthcare landscapes. As the global burden of cancer continues to escalate, there is an escalating demand for innovative and effective solutions that offer improved outcomes while minimizing patient morbidity. Advancements in imaging technologies, such as MRI, CT, and ultrasound, are expected to further refine the precision and accuracy of interventional oncology procedures, enabling clinicians to better visualize and target tumors with unprecedented precision. These technological innovations will pave the way for the development of next-generation interventional oncology devices that offer enhanced efficacy, safety, and patient outcomes.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumour Ablation, Non-thermal Tumour Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE)), By Cancer Type (Liver, Kidney, Lung, Bone, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Interventional Oncology Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Interventional Oncology Devices Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News